CD8A and neoplasm: The scavenger receptor type I class B receptor (SR-B1) expressed on the surface of tumor cells is a receptor for ApoA-I and this allows SR-B1 to aggregate chimeric proteins on the surface of tumor cells to deliver IL-15 to NK and CD8+ T cells.